members of society, including women, children, and 
those living with HIV/AIDS, become infected. 
According to the World Health Organization 
(WHO), HIV/AIDS, tuberculosis, and malaria ac-
counted for more than 5,700,000 deaths in 2001 
and caused debilitating illnesses in millions more. 
(12) Tuberculosis is the cause of death for one 
out of every three people with AIDS worldwide and 
is a highly communicable disease. HIV infection is 
the leading threat to tuberculosis control. Because 
HIV infection so severely weakens the immune sys-
tem, individuals with HIV and latent tuberculosis in-
fection have a 100 times greater risk of developing 
active tuberculosis diseases thereby increasing the 
risk of spreading tuberculosis to others. Tuber-
culosis, in turn, accelerates the onset of AIDS in in-
dividuals infected with HIV. 
(13) Malaria, the most deadly of all tropical 
parasitic diseases, has been undergoing a dramatic 
resurgence in recent years due to increasing resist-
ance of the malaria parasite to inexpensive and ef-
fective drugs. At the same time, increasing resist-
ance of mosquitoes to standard insecticides makes 
control of transmission difficult to achieve. The 
World Health Organization estimates that between
300,000,000 and 500,000,000 new cases of malaria 
occur each year, and annual deaths from the disease 
number between 2,000,000 and 3,000,000. Persons 
infected with HIV are particularly vulnerable to the 
malaria parasite. The spread of HIV infection con-
tributes to the difficulties of controlling resurgence 
of the drug resistant malaria parasite. 
(14) Although HIV/AIDS is first and foremost 
a health problem, successful strategies to stem the 
spread of the pandemic will require not only medical 
interventions, the strengthening of health care deliv-
ery systems and infrastructure and determined na-
tional leadership and increased budgetary allocations 
for the health sector in countries affected by the epi-
demic but also measures to address the social and 
behavioral causes of the problem and its impact on 
families, communities, and societal sectors. 
(15) Basic interventions to prevent new HIV in-
fections and to bring care and treatment to people 
living with AIDS, such as voluntary counseling and 
testing and mother-to-child transmission programs, 
are achieving meaningful results and are cost-effec-
tive. The challenge is to expand these interventions 
from a pilot program basis to a national basis in a 
coherent and sustainable manner.
(16) Appropriate treatment of individuals with 
HIV/AIDS can prolong the lives of such individuals, 
preserve their families, prevent children from becom-
ing orphans, and increase productivity of such indi-
viduals by allowing them to lead active lives and re-
duce the need for costly hospitalization for treatment 
of opportunistic infections caused by HIV. 
(17) United States nongovernmental organiza-
tions, including faith-based organizations, with expe-
rience in health care and HIV/AIDS counseling, 
have proven effective in combating the HIV/AIDS 
pandemic and can be a resource in assisting indige-
nous organizations in severely affected countries in 
their efforts to provide treatment and care for indi-
viduals infected with HIV/AIDS. 
(18) The magnitude and scope of the HIV/
AIDS crisis demands a comprehensive, long-term, 
international response focused upon addressing the 
causes, reducing the spread, and ameliorating the 
consequences of the HIV/AIDS pandemic, includ-
ing—
(A) prevention and education, care and 
treatment, basic and applied research, and 
training of health care workers, particularly at 
the community and provincial levels, and other
community workers and leaders needed to cope 
with the range of consequences of the HIV/
AIDS crisis; 
(B) development of health care infrastruc-
ture and delivery systems through cooperative 
and coordinated public efforts and public and 
private partnerships; 
(C) development and implementation of 
national 
and 
community-based 
multisector 
strategies that address the impact of HIV/
AIDS on the individual, family, community, and 
nation and increase the participation of at-risk 
populations in programs designed to encourage 
behavioral and social change and reduce the 
stigma associated with HIV/AIDS; and
(D) coordination of efforts between inter-
national organizations such as the Global Fund 
to Fight AIDS, Tuberculosis and Malaria, the 
Joint United Nations Programme on HIV/
AIDS (UNAIDS), the World Health Organiza-
tion (WHO), national governments, and private 
sector organizations. 
(19) The United States has the capacity to lead 
and enhance the effectiveness of the international 
community’s response by—
(A) 
providing 
substantial 
financial 
resources, technical expertise, and training, par-
ticularly of health care personnel and commu-
nity workers and leaders; 
(B) promoting vaccine and microbicide re-
search and the development of new treatment 
protocols in the public and commercial pharma-
ceutical research sectors; 
(C) making available pharmaceuticals and 
diagnostics for HIV/AIDS therapy; 
(D) encouraging governments and commu-
nity-based organizations to adopt policies that 
treat HIV/AIDS as a multisectoral problem af-
fecting not only health but other areas such as 
education, the economy, the family and society, 
and assisting them to develop and implement 
programs corresponding to these needs; and 
(E) encouraging active involvement of the 
private sector, including businesses, pharma-
ceutical and biotechnology companies, the med-
ical and scientific communities, charitable foun-
dations, private and voluntary organizations 
and nongovernmental organizations, faith-based 
organizations, community-based organizations, 
and other nonprofit entities.
SEC. 3. DEFINITIONS. 
In this Act: 
(1) AIDS.—The term ‘‘AIDS’’ means the ac-
quired immune deficiency syndrome. 
(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘appropriate congressional com-
mittees’’ means the Committee on Foreign Relations 
of the Senate and the Committee on International 
Relations of the House of Representatives. 
(3) DESIGNATED
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘designated congressional commit-
tees’’ means the Committee on Foreign Relations 
and the Committee on Health, Education, Labor, 
and Pensions of the Senate and the Committee on 
International Relations and the Committee on En-
ergy and Commerce of the House of Representa-
tives. 
(4) GLOBAL FUND.—The term ‘‘Global Fund’’ 
means the public-private partnership known as the 
Global Fund to Fight AIDS, Tuberculosis and Ma-
laria that was established upon the call of the 
United Nations Secretary General in April 2001. 
(5) HIV.—The term ‘‘HIV’’ means the human 
immunodeficiency virus, the pathogen that causes 
AIDS.
(3) providing increased resources for United 
States bilateral efforts, particularly for technical as-
sistance and training, to combat HIV/AIDS, tuber-
culosis, and malaria; 
(4) encouraging the expansion of private sector 
efforts and expanding public-private sector partner-
ships to combat HIV/AIDS; and 
(5) intensifying efforts to support the develop-
ment of vaccines and treatment for HIV/AIDS, tu-
berculosis, and malaria. 
SEC. 5. AUTHORITY TO CONSOLIDATE AND COMBINE RE-
PORTS. 
With respect to the reports required by this Act to 
be submitted by the President, to ensure an efficient use 
of resources, the President may, in his discretion and not-
withstanding any other provision of this Act, consolidate 
or combine any of these reports, except for the report re-
quired by section 101 of this Act, so long as the required 
elements of each report are addressed and reported within 
a 90-day period from the original deadline date for sub-
mission of the report specified in this Act. The President 
may also enter into contracts with organizations with rel-
evant expertise to develop, originate, or contribute to any 
of the reports required by this Act to be submitted by the 
President.
TITLE I—POLICY PLANNING AND 
COORDINATION 
SEC. 101. DEVELOPMENT OF A COMPREHENSIVE, FIVE-
YEAR, GLOBAL STRATEGY. 
(a) STRATEGY.—The President shall establish a com-
prehensive, integrated, five-year strategy to combat global 
HIV/AIDS that promotes the goals and objectives of the 
Declaration of Commitment on HIV/AIDS, adopted by the 
United Nations General Assembly at its Special Session 
on HIV/AIDS in June 2001, and strengthens the capacity 
of the United States to be an effective leader of the inter-
national campaign against HIV/AIDS. Such strategy 
shall—
(1) include specific objectives, multisectoral ap-
proaches, and specific strategies to treat individuals 
infected with HIV/AIDS and to prevent the further
spread of HIV infections, with a particular focus on 
the needs of women, young people, and children; 
(2) assign priorities for relevant Executive 
branch agencies; 
(3) improve coordination among relevant Exec-
utive branch agencies and foreign governments and 
international organizations; 
(4) project general levels of resources needed to 
achieve the stated objectives;
(5) expand public-private partnerships and the 
leveraging of resources; and 
(6) maximize United States capabilities in the 
areas of technical assistance and training and re-
search, including vaccine research. 
(b) REPORT.—
(1) IN
GENERAL.—Not later than 270 days 
after the date of enactment of this Act, the Presi-
dent shall submit to designated congressional com-
mittees a report setting forth the strategy described 
in subsection (a). 
(2) REPORT CONTENTS.—The report required 
by paragraph (1) shall include a discussion of the 
elements described in paragraph (3) and may in-
clude a discussion of additional elements relevant to 
the strategy described in subsection (a). Such dis-
cussion may include an explanation as to why a par-
ticular element described in paragraph (3) is not rel-
evant to such strategy. 
(3) REPORT
ELEMENTS.—The elements re-
ferred to in paragraph (2) are the following: 
(A) The objectives, general and specific, of 
the strategy. 
(B) A description of the criteria for deter-
mining success of the strategy.
(C) A description of the manner in which 
the strategy will address the fundamental ele-
ments of prevention and education; care and 
treatment, including increasing access to phar-
maceuticals and to vaccines and microbicides 
when available; research, including incentives 
for vaccine development and new protocols; and 
training of health care workers, and the devel-
opment of health care infrastructure and deliv-
ery systems. 
(D) A description of the manner in which 
the strategy will promote the development and 
implementation of national and community-
based multisectoral strategies and programs, in-
cluding those designed to enhance leadership 
capacity particularly at the community level. 
(E) A description of the specific strategies 
developed to meet the unique needs of women, 
including the empowerment of women in inter-
personal situations, young people and children, 
including those orphaned by HIV/AIDS. 
(F) A description of the programs to be 
undertaken to maximize United States con-
tributions in the areas of technical assistance, 
training particularly of health care workers and
community-based leaders in affected sectors, 
and research including the promotion of re-
search on vaccines. 
(G) An identification of the relevant Exec-
utive branch agencies that will be involved and 
the assignment of priorities to those agencies. 
(H) A description of the role of each rel-
evant Executive branch agency and the types of 
programs that the agency will be undertaking. 
(I) A description of the mechanisms that 
will be utilized to coordinate the efforts of the 
relevant Executive branch agencies, to avoid du-
plication of efforts, to enhance on-site coordina-
tion efforts, and to ensure that each agency un-
dertakes programs primarily in those areas 
where the agency has the greatest expertise, 
technical capabilities, and potential for success. 
(J) A description of the mechanisms that 
will be utilized to ensure greater coordination 
between the United States and foreign govern-
ments and international organizations including 
the Global Fund, UNAIDS, international finan-
cial institutions, and private sector organiza-
tions.
(K) The level of resources that will be 
needed on an annual basis and the manner in 
which those resources would generally be allo-
cated among relevant Executive agencies. 
(L) A description of the mechanisms to be 
established for monitoring and evaluating pro-
grams and for terminating unsuccessful pro-
grams. 
(M) A description of the manner in which 
private, nongovernmental entities will factor 
into the United States Government-led effort 
and a description of the type of partnerships 
that will be created to maximize the capabilities 
of these private sector entities and to leverage 
resources. 
(N) A description of the manner in which 
the United States strategy for combating HIV/
AIDS relates to and promotes the goals and ob-
jectives of the United Nations General Assem-
bly’s Declaration of Commitment on HIV/
AIDS. 
(O) A description of the ways in which 
United States leadership will be used to en-
hance the overall international response to the 
HIV/AIDS pandemic and particularly to height-
en the engagement of the member states of the 
G–8 and to strengthen key financial and coordi-
nation mechanisms such as the Global Fund 
and UNAIDS. 
(P) A description of the manner in which 
the United States strategy for combating HIV/
AIDS relates to and enhances other United 
States assistance strategies in developing coun-
tries. 
SEC. 102. COMPREHENSIVE PLAN TO EMPOWER WOMEN TO 
PREVENT THE SPREAD OF HIV/AIDS. 
(a) STATEMENT OF POLICY.—It is in the national in-
terest of the United States—
(1) to assist in empowering women socially, eco-
nomically, and intellectually to prevent coercive prac-
tices which contribute to the spread of HIV/AIDS; 
(2) to ensure that there are affordable effective 
female controlled preventative technologies widely 
available; 
(3) to assist in providing adequate pre- and 
post-natal care to women infected with HIV or living 
with AIDS to prevent an increase in the number of 
AIDS orphans; and
(4) to educate communities in order to lessen 
the stigma facing women who are infected with HIV 
or living with AIDS. 
(b) DEVELOPMENT OF PLAN.—The United States 
Agency for International Development, working in con-
junction with other relevant Executive branch agencies, 
shall develop a comprehensive plan to empower women to 
protect themselves against the spread of HIV/AIDS. The 
plan shall include—
(1) immediately providing women greatly in-
creased access to and program support for currently 
available prevention technologies for women and 
microbicides when they become available; 
(2) providing funding for research to develop 
safe, effective, usable microbicides, including support 
for—
(A) development and preclinical evaluation 
of topical microbicides; 
(B) the conduct of clinical studies of can-
didate microbicides to assess safety, accept-
ability, and effectiveness in reducing the HIV 
infection and other sexually transmitted infec-
tions;
(C) behavioral and social science research 
relevant to microbicide development, testing, ac-
ceptability, and use; and 
(D) introductory studies of safe and effec-
tive microbicides in developing countries; 
(3) increasing women’s access to microfinance 
programs; 
(4) comprehensive education for women and 
girls including health education that emphasizes 
skills building on negotiation and the prevention of 
sexually transmitted infections and other related re-
productive health risks and strategies that empha-
size the delay of sexual debut; 
(5) community-based strategies to combat gen-
der-based violence and sexual coercion of women and 
minors; 
(6) expansion of peer education strategies for 
men which emphasize responsible sexual behavior 
and consultation with their wives and partners in 
making decisions about sex and reproduction; 
(7) resources for households headed by females 
caring for AIDS orphans; 
(8) followup monitoring of and care and sup-
port for post-natal women living with HIV or at 
high risk of infection; and
(9) targeted plans to reduce the vulnerability of 
HIV/AIDS for women, young people, and children 
who are refugees or internally displaced persons. 
(c) REQUIREMENT.—The plan shall specify, for the 
assistance to achieve each of the objectives set forth in 
paragraphs (1) through (9) of subsection (b), the section 
of the Foreign Assistance Act of 1961 or other law that 
authorizes such assistance. 
(d) STAFFING.—The Administrator of the United 
States Agency for International Development shall ensure 
that the Agency dedicates a sufficient number of employ-
ees to implementing the plan described in subsection (b). 
(e) REPORT.—Not later than 270 days after the date 
of enactment of this Act and every year for the next 3 
years thereafter, the Administrator of the United States 
Agency for International Development shall submit to the 
appropriate congressional committees a report on the plan 
being implemented by the United States Agency for Inter-
national Development on empowering women in order to 
prevent the spread of HIV/AIDS. The report shall include 
a description of—
(1) the programs being carried out that are 
specifically targeted at women and girls to educate 
them about the spread of HIV/AIDS and the use 
and availability of currently available prevention
technologies for women, together with the number of 
women and girls reached through these programs; 
(2) the steps taken to increase the availability 
of such technologies; and 
(3) the progress on developing a safe, effective, 
user-friendly microbicide. 
SEC. 103. HIV/AIDS RESPONSE COORDINATOR. 
(a) ESTABLISHMENT OF POSITION.—Section 1 of the 
State Department Basic Authorities Act of 1956 (22 
U.S.C. 265(a)) is amended—
(1) by redesignating subsections (f) and (g) as 
subsections (g) and (h), respectively; and 
(2) by adding after subsection (e) the following: 
‘‘(f) HIV/AIDS RESPONSE COORDINATOR.—
‘‘(1) IN GENERAL.—There shall be within the 
Department of State a Coordinator of United States 
Government Activities to Combat HIV/AIDS Glob-
ally, who shall be appointed by the President, by and 
with the advice and consent of the Senate. The Co-
ordinator shall report directly to the Secretary of 
State and shall have the rank and status of ambas-
sador. 
‘‘(2) DUTIES.—
‘‘(A) IN GENERAL.—The Coordinator shall 
have primary responsibility for the oversight
and coordination of all international activities of 
the United States Government to combat the 
HIV/AIDS pandemic, including all programs, 
projects, and activities of the United States 
Government under titles I through IV of the 
United States Leadership Against HIV/AIDS, 
Tuberculosis, and Malaria Act of 2002 or any 
amendment made by those titles. 
‘‘(B) SPECIFIC DUTIES.—The duties of the 
Coordinator shall specifically include the fol-
lowing:
‘‘(i) Ensuring program and policy co-
ordination among the relevant Executive 
branch agencies. 
‘‘(ii) Ensuring that each relevant Ex-
ecutive branch agency undertakes pro-
grams primarily in those areas where the 
agency has the greatest expertise, technical 
capabilities, and potential for success. 
‘‘(iii) Avoiding duplication of effort. 
‘‘(iv) Ensuring coordination of rel-
evant Executive branch agency activities in 
the field. 
‘‘(v) Pursuing coordination with other 
countries and international organizations.
‘‘(vi) Resolving policy, program, and 
funding disputes among the relevant Exec-
utive branch agencies.’’. 
(b) FIRST COORDINATOR.—The President may des-
ignate the incumbent Special Representative of the Sec-
retary of State for HIV/AIDS as of the date of enactment 
of this Act as the first Coordinator of United States Gov-
ernment Activities to Combat HIV/AIDS Globally. 
(c) RESOURCES.—Not later than 90 days after the 
date of enactment of this Act, the President shall identify 
the necessary financial and personnel resources that would 
be assigned to the HIV/AIDS Response Coordinator to es-
tablish and sustain the duties and supporting activities as-
signed to the Coordinator by this Act. 
SEC. 104. REPORT ON REVERSING THE EXODUS OF CRIT-
ICAL TALENT. 
(a) IN GENERAL.—Not later than one year after the 
date of enactment of this Act, the President shall submit 
a report to designated congressional committees analyzing 
the emigration of critically important medical and public 
health personnel, including physicians, nurses, and super-
visors from sub-Saharan African countries that are acute-
ly impacted by HIV/AIDS. 
(b) ELEMENTS OF THE REPORT.—The report shall 
include—
(1) an analysis of the causes for the exodus of 
such personnel, the present and projected trend 
lines, and the impact on the stability of health infra-
structures; and 
(2) a description of incentives and programs 
that the United States could provide, in concert with 
other private and public sector partners and inter-
national organizations, to stabilize health institu-
tions by encouraging critical personnel to remain in 
their home countries. 
TITLE II—SUPPORT FOR MULTI-
LATERAL FUNDS, PROGRAMS, 
AND PUBLIC-PRIVATE PART-
NERSHIPS 
SEC. 201. SENSE OF CONGRESS ON PUBLIC-PRIVATE PART-
NERSHIPS. 
(a) FINDINGS.—Congress makes the following find-
ings: 
(1) Innovative partnerships between govern-
ments and organizations in the private sector 
(including foundations, universities, corporations, 
faith-based and community-based organizations, and 
other nongovernmental organizations) have pro-
liferated in recent years, particularly in the area of 
health.
(2) Public-private sector partnerships multiply 
local and international capacities to strengthen the 
delivery of health services in developing countries 
and to accelerate research for vaccines and other 
pharmaceutical products that are essential to combat 
infectious diseases decimating the populations of 
these countries. 
(3) These partnerships maximize the unique ca-
pabilities of each sector while combining financial 
and other resources, scientific knowledge, and exper-
tise toward common goals which neither the public 
nor the private sector can achieve alone. 
(4) Sustaining existing public-private partner-
ships and building new ones are critical to the suc-
cess of the international community’s efforts to com-
bat HIV/AIDS and other infectious diseases around 
the globe. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that—
(1) the sustainment and promotion of public-
private partnerships should be a priority element of 
the strategy pursued by the United States to combat 
the HIV/AIDS pandemic and other global health cri-
ses; and
(2) the United States should systematically 
track the evolution of these partnerships and work 
with others in the public and private sector to profile 
and build upon those models that are most effective. 
SEC. 202. PARTICIPATION IN THE GLOBAL FUND TO FIGHT 
AIDS, TUBERCULOSIS, AND MALARIA. 
(a) AUTHORITY FOR UNITED STATES PARTICIPA-
TION.—
(1) 
UNITED
STATES
PARTICIPATION.—The 
United States is hereby authorized to participate in 
the Global Fund to Fight AIDS, Tuberculosis and 
Malaria. 
(2) PRIVILEGES AND IMMUNITIES.—The Global 
Fund shall be considered a public international orga-
nization for purposes of section 1 of the Inter-
national Organizations Immunities Act (22 U.S.C. 
288). 
(b) REPORTS TO CONGRESS.—Not later than one 
year after the date of the enactment of this Act, and annu-
ally thereafter for the duration of the Global Fund, the 
President shall submit to the appropriate congressional 
committees a report on the Global Fund, including con-
tributions pledged, contributions received (including dona-
tions from the private sector), projects funded, and the
mechanisms established for transparency and account-
ability in the grant making process. 
(c) UNITED STATES FINANCIAL PARTICIPATION.—
(1) AUTHORIZATION OF APPROPRIATIONS.—In 
addition to funds otherwise available for such pur-
pose, there are authorized to be appropriated to the 
President $750,000,000 for the fiscal year 2003 and 
$1,200,000,000 for the fiscal year 2004 for con-
tributions to the Global Fund.
(2) AVAILABILITY OF FUNDS.—Amounts appro-
priated pursuant to paragraph (1) are authorized to 
remain available until expended. 
(3) REPROGRAMMING
OF
FISCAL
YEAR
2001 
FUNDS.—Funds made available for fiscal year 2001 
under section 141 of the Global AIDS and Tuber-
culosis Relief Act of 2000—
(A) are authorized to remain available 
until expended; and 
(B) shall be transferred to, merged with, 
and made available for the same purposes as, 
funds made available for fiscal year 2002 under 
paragraph (1). 
(4) STATUTORY
CONSTRUCTION.—Nothing in 
this Act may be construed to substitute for, or re-
duce resources provided under any other law for bi-
lateral and multilateral HIV/AIDS, tuberculosis, and 
malaria programs. 
SEC. 
203. 
VOLUNTARY 
CONTRIBUTIONS 
TO 
INTER-
NATIONAL VACCINE FUNDS. 
(a) VACCINE FUND.—Section 302(k) of the Foreign 
Assistance Act of 1961 (22 U.S.C. 2222(k)) is amended—
(1) by striking ‘‘$50,000,000’’ and all that fol-
lows through ‘‘2002’’ and inserting ‘‘$60,000,000 
for the fiscal year 2003 and $70,000,000 for the fis-
cal year 2004’’; and 
(2) by striking ‘‘Global Alliance for Vaccines 
and Immunizations’’ and inserting ‘‘Vaccine Fund’’. 
(b) INTERNATIONAL AIDS VACCINE INITIATIVE.—
Section 302(l) of the Foreign Assistance Act of 1961 (22 
U.S.C. 2222(l)) is amended by striking ‘‘$10,000,000’’ 
and all that follows through ‘‘2002’’ and inserting 
‘‘$12,000,000 for the fiscal year 2003 and $15,000,000 
for the fiscal year 2004’’. 
(c) MALARIA VACCINE INITIATIVE OF THE PROGRAM 
FOR
APPROPRIATE
TECHNOLOGIES
IN
HEALTH 
(PATH).—Section 302 of the Foreign Assistance Act of 
1961 (22 U.S.C. 2222)) is amended by adding at the end 
the following new subsection: 
‘‘(m) In addition to amounts otherwise available 
under this section, there are authorized to be appropriated
to the President $5,000,000 for the fiscal year 2003 and 
$6,000,000 for the fiscal year 2004 to be available for 
United States contributions to the Malaria Vaccine Initia-
tive of the Program for Appropriate Technologies in 
Health (PATH).’’. 
TITLE III—BILATERAL EFFORTS 
Subtitle A—General Assistance and 
Programs 
SEC. 301. ASSISTANCE TO COMBAT HIV/AIDS. 
(a) AMENDMENT OF THE FOREIGN ASSISTANCE ACT 
OF 1961.—Chapter 1 of part I of the Foreign Assistance 
Act of 1961 (22 U.S.C. 2151 et seq.) is amended—
(1) in section 104(c) (22 U.S.C. 2151b(c)), by 
striking paragraphs (4) through (7); and 
(2) by inserting after section 104 the following 
new section: 
‘‘SEC. 104A. ASSISTANCE TO COMBAT HIV/AIDS. 
‘‘(a) FINDING.—Congress recognizes that the alarm-
ing spread of HIV/AIDS in countries in sub-Saharan Afri-
ca and other developing countries is a major global health, 
national security, and humanitarian crisis. 
‘‘(b) POLICY.—It is a major objective of the foreign 
assistance program of the United States to provide assist-
ance for the prevention, treatment, and control of HIV/
AIDS. The United States and other developed countries
should provide assistance to countries in sub-Saharan Af-
rica and other countries and areas to control this crisis 
through HIV/AIDS prevention, treatment, monitoring, 
and related activities, particularly activities focused on 
women and youth, including strategies to prevent mother-
to-child transmission of the HIV infection. 
‘‘(c) AUTHORIZATION.—
‘‘(1) IN
GENERAL.—Consistent with section 
104(c), the President is authorized to furnish assist-
ance, on such terms and conditions as the President 
may determine, to prevent, treat, and monitor HIV/
AIDS, and carry out related activities, in countries 
in sub-Saharan Africa and other countries and 
areas. 
‘‘(2) ROLE OF NGOS.—It is the sense of Con-
gress that the President should provide an appro-
priate level of assistance under paragraph (1) 
through nongovernmental organizations in countries 
in sub-Saharan Africa and other countries and areas 
affected by the HIV/AIDS pandemic. 
‘‘(3) 
COORDINATION
OF
ASSISTANCE
EF-
FORTS.—The President shall coordinate the provi-
sion of assistance under paragraph (1) with the pro-
vision of related assistance by the Joint United Na-
tions Programme on HIV/AIDS (UNAIDS), the